Migraine Prevention: Evidence-Based Treatments and Lifestyle Strategies

The goal of preventive therapy is to reduce attack frequency, severity, duration, and disability; improve acute treatment response; prevent medication-overuse headache; and enhance quality of life. Indicated when: ≥4 migraine days/month, disabling attacks, contraindication/failure to acute meds, or patient preference.

Oral Preventive Medications (First-Line per AHS/AAN Guidelines)

ClassExamplesKey Points
Beta-blockersPropranolol, metoprolol, timololLevel A evidence; avoid in asthma, bradycardia, depression.
AnticonvulsantsTopiramate, valproate (avoid in pregnancy), zonisamideTopiramate: weight loss, cognitive side effects (word-finding).
AntidepressantsAmitriptyline, nortriptyline, venlafaxineTCAs: sedating, anticholinergic; SNRIs for comorbid depression/anxiety.
Calcium channel blockersVerapamilLess evidence; useful if other classes contraindicated.
CGRP mAbs (oral)Atogepant, rimegepantNewer; also approved for acute treatment; no titration needed.

Injectable/Infusion Preventives

  • CGRP Monoclonal Antibodies (monthly/quarterly SC/IV): Erenumab, fremanezumab, galcanezumab, eptinezumab. High efficacy, excellent tolerability, no daily pill burden.
  • OnabotulinumtoxinA (Botox): FDA-approved for chronic migraine (≥15 headache days/mo). 31-site injection protocol q12 weeks. Effective for chronic migraine with medication overuse.

Neuromodulation Devices

  • External (non-invasive): Cefaly (supraorbital V1 stimulation), gammaCore (nVNS), Nerivio (remote electrical neuromodulation), Relivion (combined occipital/trigeminal).
  • Implanted (invasive): Occipital nerve stimulator, sphenopalatine ganglion stimulator—reserved for refractory cases.

Lifestyle Modifications (SEEDS Mnemonic)

  • Sleep: Consistent schedule, 7–9 hrs, treat apnea.
  • Exercise: 150 min/week moderate aerobic (reduces frequency ~30%).
  • Eat: Regular meals, hydration, avoid triggers (aged cheese, alcohol, aspartame, MSG, nitrates).
  • Diary: Track triggers, patterns, treatment response.
  • Stress management: CBT, mindfulness, biofeedback, relaxation training.

Special Populations

  • Pregnancy: Avoid valproate, topiramate, CGRP mAbs (limited data). Prefer propranolol, amitriptyline, magnesium, behavioral therapy.
  • Children/Adolescents: Topiramate, propranolol, amitriptyline; CBT + lifestyle first-line.
  • Older adults: Start low, go slow; watch drug interactions, falls, cognitive effects.

Monitoring & Expectations

  • Therapeutic trial: 2–3 months at target dose.
  • 50% responder rate (≥50% reduction in migraine days) is typical benchmark.
  • Combination therapy (medication + behavioral) often superior to either alone.
  • Reassess every 6–12 months; taper if sustained remission.

Migraine - Related Articles